Clinical pharmacology of dronedarone: Implications for the therapy of atrial fibrillation

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 15, Issue 4 SUPPL., 2010, Pages

  Dorian, Paul ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

atrial fibrillation; dronedarone; pharmacology; pharmocokinetics

Indexed keywords

AMIODARONE; CARBAMAZEPINE; CREATININE; DIGOXIN; DILTIAZEM; DRONEDARONE; GLYCOPROTEIN P; METOPROLOL; PANTOPRAZOLE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; SIMVASTATIN; VERAPAMIL; WARFARIN; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETOCONAZOLE; LOSARTAN; MEVINOLIN; PLACEBO; ROSUVASTATIN;

ARTICLE; BODY WEIGHT; CLINICAL PHARMACOLOGY; CREATININE CLEARANCE; DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; GENDER; GLOMERULUS FILTRATION RATE; GRAPEFRUIT JUICE; HEART ATRIUM FIBRILLATION; KIDNEY DYSFUNCTION; PRIORITY JOURNAL; SINUS NODE DYSFUNCTION; AGE; ANTIARRHYTHMIC ACTIVITY; AREA UNDER THE CURVE; ATRIAL FIBRILLATION; BRADYCARDIA; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COMPETITION; DRUG CONTRAINDICATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG STRUCTURE; FOOD DRUG INTERACTION; HEART DISEASE; HUMAN; LIPID DIET; MAXIMUM PLASMA CONCENTRATION; QT PROLONGATION; REPEATED DRUG DOSE; SIDE EFFECT; SINGLE DRUG DOSE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL AVAILABILITY; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HALF-LIFE; HUMANS; P-GLYCOPROTEIN;

EID: 78651402163     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410367792     Document Type: Article

References (15)

1. Multaq [prescribing information]. Bridgewater, NJ: sanofi-aventis US LLC ; 2009.
2. Kathofer S., Thomas D., Karle CA The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc Drug Rev. 2005 ; 23 (3). 217-230.
3. sanofi-aventis. Investigator's brochure: SR33598B dronedarone hydrochloride. Bridgewater, NJ: sanofi-aventis US LLC ; 2009.
4. Tschuppert Y., Buclin T., Rothuizen LE, et al. Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol. 2007 ; 64 (6). 785-791.
5. Becquemont L., Neuvonen M., Verstuyft C., et al. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics. Clin Pharmacol Ther. 2007 ; 81 (5). 679-684.
6. Werner D., Wuttke H., Fromm MF, et al. Effect of amiodarone on the plasma levels of metoprolol. Am J Cardiol. 2004 ; 94 (10). 1319-1321.
7. O'Reilly RA, Trager WF, Rettie AE, Goulart DA Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans. Clin Pharmacol Ther. 1987 ; 42 (3). 290-294.
8. Nademanee K., Kannan R., Hendrickson J., Ookhtens M., Kay I., Singh BN Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol. 1984 ; 4 (1). 111-116.
9. Pollak P., Alsohaibani F. Changes in serum urea and creatinine during long-term therapy with amiodarone [abstract]. Clin Pharmacol Ther. 2004 ; 75 (2). P5.
10. Zareba KM Dronedarone: a new antiarrhythmic agent. Drugs Today (Barc). 2006 ; 42 (2). 75-86.
11. Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007 ; 357 (10). 987-999.
12. Hohnloser SH, Crijns HJ, van Eickels M., et al, ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009 ; 360 (7). 668-678.
13. Damy T., Pousset F., Caplain H., Hulot JS, Lechat P. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects. Fundam Clin Pharmacol. 2004 ; 18 (1). 113-123.
14. Le Heuzey JY, De Ferrari GM, Radzik D., Santini M., Zhu J., Davy JM A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol. 2010. In press.
15. Turgeon J., Dorian P. Principles of clinical pharmacology. In: Saksena S, Camm AJ, Goldschlager N, Dorian P, Boyden PA, eds. Electrophysiological Disorders of the Heart. Philadelphia, PA: Elsevier Inc ; 2005: 87-94.